受强制性开放获取政策约束的文章 - kulke m了解详情
无法在其他位置公开访问的文章:4 篇
Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor
A Karpathakis, H Dibra, C Pipinikas, A Feber, T Morris, J Francis, D Oukrif, ...
Clinical Cancer Research 22 (1), 250-258, 2016
强制性开放获取政策: Cancer Research UK, National Institute for Health Research, UK
Clinical implications of pathogenic germline variants in small intestine neuroendocrine tumors (SI-NETs)
K Perez, MH Kulke, A Chittenden, C Ukaegbu, K Astone, H Alexander, ...
JCO Precision Oncology 5, 808-816, 2021
强制性开放获取政策: Susan G. Komen
Cutaneous paraneoplastic granulomatous eruptions secondary to metastatic carcinoid tumour
JM Cohen, VE Nambudiri, MH Kulke, DJ Todd, GF Murphy, NR LeBoeuf
British Journal of Dermatology 172 (5), 1451-1454, 2015
强制性开放获取政策: US National Institutes of Health, Howard Hughes Medical Institute
Reply to A. Koumarianou et al and J. Hadoux et al
JA Chan, MH Kulke
Journal of Clinical Oncology 31 (7), 977-978, 2013
强制性开放获取政策: US National Institutes of Health
可在其他位置公开访问的文章:99 篇
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J Strosberg, G El-Haddad, E Wolin, A Hendifar, J Yao, B Chasen, E Mittra, ...
New England Journal of Medicine 376 (2), 125-135, 2017
强制性开放获取政策: US National Institutes of Health
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
JC Yao, N Fazio, S Singh, R Buzzoni, C Carnaghi, E Wolin, J Tomasek, ...
The Lancet 387 (10022), 968-977, 2016
强制性开放获取政策: US National Institutes of Health
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
MH Kulke, LB Anthony, DL Bushnell, WW De Herder, SJ Goldsmith, ...
Pancreas 39 (6), 735-752, 2010
强制性开放获取政策: US National Institutes of Health
Consensus guidelines for the management and treatment of neuroendocrine tumors
PL Kunz, D Reidy-Lagunes, LB Anthony, EM Bertino, K Brendtro, JA Chan, ...
Pancreas 42 (4), 557-577, 2013
强制性开放获取政策: US National Institutes of Health
Cancer susceptibility gene mutations in individuals with colorectal cancer
MB Yurgelun, MH Kulke, CS Fuchs, BA Allen, H Uno, JL Hornick, ...
Journal of Clinical Oncology 35 (10), 1086-1095, 2017
强制性开放获取政策: US National Institutes of Health
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing
J Li, L Wang, H Mamon, MH Kulke, R Berbeco, GM Makrigiorgos
Nature medicine 14 (5), 579-584, 2008
强制性开放获取政策: US National Institutes of Health
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
A Glaviano, ASC Foo, HY Lam, KCH Yap, W Jacot, RH Jones, H Eng, ...
Molecular cancer 22 (1), 138, 2023
强制性开放获取政策: National Medical Research Council, Singapore, Alex's Lemonade Stand
O 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
MH Kulke, JL Hornick, C Frauenhoffer, S Hooshmand, DP Ryan, ...
Clinical Cancer Research 15 (1), 338-345, 2009
强制性开放获取政策: US National Institutes of Health
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
J Strosberg, E Wolin, B Chasen, M Kulke, D Bushnell, M Caplin, RP Baum, ...
Journal of Clinical Oncology 36 (25), 2578-2584, 2018
强制性开放获取政策: US National Institutes of Health
The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas
JR Strosberg, D Coppola, DS Klimstra, AT Phan, MH Kulke, GA Wiseman, ...
Pancreas 39 (6), 799-800, 2010
强制性开放获取政策: US National Institutes of Health
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
J Souglakos, J Philips, R Wang, S Marwah, M Silver, M Tzardi, J Silver, ...
British journal of cancer 101 (3), 465-472, 2009
强制性开放获取政策: US National Institutes of Health
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting
MH Kulke, LL Siu, JE Tepper, G Fisher, D Jaffe, DG Haller, LM Ellis, ...
Journal of Clinical oncology 29 (7), 934-943, 2011
强制性开放获取政策: US National Institutes of Health
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
JM Francis, A Kiezun, AH Ramos, S Serra, CS Pedamallu, ZR Qian, ...
Nature genetics 45 (12), 1483-1486, 2013
强制性开放获取政策: US National Institutes of Health, Cancer Research UK
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
BM Wolpin, C Rizzato, P Kraft, C Kooperberg, GM Petersen, Z Wang, ...
Nature genetics 46 (9), 994-1000, 2014
强制性开放获取政策: US National Institutes of Health, Howard Hughes Medical Institute, Cancer …
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group …
PL Kunz, PJ Catalano, H Nimeiri, GA Fisher, TA Longacre, CJ Suarez, ...
Journal of Clinical Oncology 36 (15_suppl), 4004-4004, 2018
强制性开放获取政策: US National Institutes of Health
Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
AJ Aguirre, JA Nowak, ND Camarda, RA Moffitt, AA Ghazani, ...
Cancer discovery 8 (9), 1096-1111, 2018
强制性开放获取政策: US National Institutes of Health, Doris Duke Charitable Foundation …
出版信息和资助信息由计算机程序自动确定